The Global Nanotechnology Drug Delivery System Market was valued at USD 48.1 Bn in 2020 and is expected to reach USD 88.2 Bn by 2027, with a growing CAGR of 9.2% during the forecast period.
Nanotechnology Drug Delivery System Market Definition
Nanotechnology is the branch of science that deals with the application substance at extremely small range I.e., 1-100 nm which are used across different fields such as biology, medicine, chemistry, and engineering. The application of nanotechnology in drug delivery system provides the potential to enhance the delivery of target specific molecules such as carbohydrates, nucleic acid, and proteins with fewer side effects. The delivery system used in transportation are nano emulsion, liposomes, nanoparticles, and other system at nanoscale.
Nanotechnology Drug Delivery System Market Dynamics
The driving factors influencing the global nanotechnology drug delivery system include growing preferences for personalized medicines and rising number of death cases due to lack of availability of appropriate dosage forms. Increase in research and development activities in nanotechnology to develop novel nanomedicines is expected to upfit the revenue of nanotechnology drug delivery system market.
For instance, researchers are currently focusing on the development of nobiletin-loaded penetration enhancer vesicles that would help to restore normal miRNA expression and maintain the antioxidant level in skin cancer. Topical delivery of nutraceutical-based formulation is expected to be safe and efficient treatment for the skin cancer therapy. Moreover, growing requirements for high stable dosage forms and rising demand for targeted drug delivery formulations are expected to uplift the growth of nanotechnology drug delivery system industry. Increasing feasibility of variable route of administrations such as inhalation further leverage the growth of nanotechnology drug delivery system industry. However, stringent government regulations for product approvals and excessive cost of nanomedicines development may hinder the growth of nanotechnology drug delivery system industry.
Global Nanotechnology Drug Delivery System Market Segmentation:
Company Profiles and Competitive Intelligence
The key players operating in the nanotechnology drug delivery system market are:
Based on technology, nanoparticle segment dominated the market in 2020 and is expected to maintain same dominance during forecast period owing to increase in research in nanoparticle-based formulations
Based on technology, nanotechnology drug delivery system market is broadly segmented into nano emulsion, nanoparticle, nanocrystal, liposomes, and micelles. Nanoparticle held the largest market share in 2020 and is expected to increase more during forecast period due to its higher drug carrying/loading capacity and contain high feasibility for different routes such as intranasal, intravascular of administrations. Moreover, parameters such as high stability rate, less dosing frequency and provide ease to incorporate hydrophobic molecules into the system, leverage the growth of nanoparticle segment in nanotechnology drug delivery system market.
Based on application, oncology segment accounted for highest market share in 2020 due to increase in number of cancer patients and rising demand for personalized medicines
Based on applications, nanotechnology drug delivery system market is segmented into oncology, cardiovascular, neurology, anti-inflammatory, and anti-infective. Oncology segment held the largest market share in 2020 and is expected to increase more during the forecast period due to rise in demand for precision and personalized medicines. Cancer has high prevalence rate as compared to the other diseases. For instance, to treat brain cancer, drugs or formulations need to cross blood brain barrier which is difficult with conventional dosage forms due to hydrophobic nature of molecules. Researchers have proved that nanoparticles showed promising results for ferrying drug molecules. Apolipoprotein E was expected to act as drug transporter across the brain. However, loperamide does not cross the blood brain barrier and was loaded into human serum albumin nanoparticles that was linked with apolipoprotein E and this formulation was directly injected into the brain for therapeutic effect. Such ongoing research on cancers and its effective treatments is expected to fuel the growth of this segment in nanotechnology drug delivery system industry.
Based on geographical region, North America held the largest market share in 2020 and expected to increase more during forecast period
Based on region, North America accounted for the highest market share in 2020 due to increasing prevalence of chronic diseases such as cancer, cardiovascular and neurological diseases. Moreover, growing number of key companies in North America region and rising demand for targeted nanomedicines fuels the growth of this region in nanotechnology drug delivery system market. For instance, North America is the world’s leading public funder of nanotechnology and it has provided more than USD 16 Bn in investments since 2001 and it is expected to increase more during the forecast period.
The report also provides in-depth analysis of nanotechnology drug delivery system market dynamics such as drivers, restraints, opportunities, and challenges
COVID-19 Impact on the Nanotechnology Drug Delivery System Market Analysis
Covid-19 has positively impacted the growth of nanotechnology drug delivery system industry. The sudden emergence of covid-19 pandemic lead to gain the focus of pharmaceutical and biotechnological companies for the development of nanotechnology-based drug formulations. This lead to increase the demand for the formulation & manufacturing of nanomedicines. Rising importance of on-site drug delivery to the covid infected patients is expected to boost the growth of nanotechnology drug delivery system market.
According to the study, the use of nano formulations stood to be effective in controlling cytokine storm which is one of the leading complications of covid-19 infection. Vaccines are one of the most promising solution to alleviate the outspread of corona virus. Nanomaterials are crucial factors that is used in designing, development, delivery, and administration of vaccines. The ongoing research on mRNA vaccine that is delivered by liposomal nanoparticle is one of the molecules that is currently in clinical trials against SARS-CoV-2. This creates opportunities for key market players for the development of treatments against covid infections which further leverage the growth of nanotechnology drug delivery system industry across the globe.
The report also provides an in-depth analysis of key trends in nanotechnology drug delivery system market
|1||Growing inventions in the use of metal-based nanoparticles for diagnostic procedures||Positive|
|2||Application of metals such as gold and silver in treatment and diagnosis||Positive|
|3||Emergence of global trend for precise diagnosis and medicines and future for multi-centered, innovative, and intelligent approach of nano-drug delivery||Positive|
|4||The growing passion for simplistic processes for the development of nanorobots and devices holds huge application in tissue diagnosis and repair mechanism||Positive|
The report also provides an in-depth analysis of recent news developments and investments
The unique insights provided by this report also includes the following:
Ask for free product review call with the author
Share your specific research requirements for a customized report
Request for due diligence and consumer centric studies
Request for study updates, segment specific and country level reports